Alexis Debernardis

About Alexis Debernardis

Alexis is a member of Crowell & Moring\'s Antitrust Group, where she represents corporate clients in a wide range of antitrust issues, including competitor collaborations, teaming arrangements, M&A, joint ventures, information sharing, interactions with competitors, and issues related to the Hart-Scott-Rodino Antitrust Improvements Act. Her experience covers several industries, in particular, healthcare providers and payers, aerospace and defense, telecommunications, and financial services, and she regularly represents clients before the U.S. antitrust agencies. Representative Matters-Representing pharmacy benefit manager in connection with FTC\'s 6(b) study-Counseling healthcare providers on potential acquisitions, partnerships, and other transactions-Represented Novant Health in its $5 billion acquisition of New Hanover Regional Medical Center, the largest hospital acquisition in North Carolina history-Advising clients regarding potential antitrust liability associated with horizontal and vertical conduct in a variety of industries, including healthcare and defense-Represented Humana before the Antitrust Division and in court in its attempted transaction with Aetna and related litigation-Represented a third party in the DOJ’s investigation and litigation of Aon\'s proposed acquisition of Willis Towers Watson-Represented AT & T in connection with several transactions, including the acquisition of DIRECTV and TimeWarner-Represented a health care system in securing FTC clearance of its merger with a competitor, including advising on compliance with the FTC’s second request-Represented United Technologies in connection with its $30 billion acquisition of Rockwell Collins-Various counseling matters related to potential transactions and competitor collaborations-Represented a third party in the private litigation regarding insulin pricing-Represented Clean Harbors in connection with its acquisition of the industrial cleaning services division of Veolia North America-Represented pharmacy benefit manager in connection with FTC investigation-Represented Bank of America Merrill Lynch, Citigroup, Commerzbank, Goldman Sachs, HSBC, and J.P. Morgan in connection with the formation of FXSpotStream LLC-Representing healthcare payers and providers before the FTC and DOJ in connection with pending transactions and investigations-Represented United Technologies in connection with its $16.5 billion acquisition of Goodrich-Conducting client training on a range of issues, including teaming, competitor communications, and compliance issues.

Experience

1. Vice President & Chief Compliance Officer, Solstice Advanced Materials

   Honeywell Technologies

   Aug 2025 — Present · Washington, DC, US

Education

• University of Florida

  B.S., Finance

  2001 — 2004

• The George Washington University Law School

  J.D.

  2005 — 2008